An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model-Reference-Cited by-同舟云学术

An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model

Published:2021-05-13 Issue:8 Volume:1 Page:2100021
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Adv NanoBio Res

Author:

Shukla Anshi¹,Cano-Mejia Juliana¹,Andricovich Jaclyn¹²,Burga Rachel A.¹²,Sweeney Elizabeth E.¹,Fernandes Rohan¹²³^ORCID

Affiliation:

1. The George Washington Cancer Center The George Washington University 800 22nd St NW, Science and Engineering Hall 8th Floor Washington DC 20052 USA

2. The Institute for Biomedical Sciences The George Washington University 2300 Eye Street NW, Ross Hall Room 561 Washington DC 20037 USA

3. Department of Medicine The George Washington University 2150 Pennsylvania Avenue, NW Suite 8-416 Washington DC 20037 USA

Funder

Alex's Lemonade Stand Foundation for Childhood Cancer

National Cancer Institute

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202100021

Reference75 articles.

1. Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma

2. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies

3. More than the genes, the tumor microenvironment in neuroblastoma

4. Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets

5. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity;Nanomedicine;2024-09-03

2. NIR-II photothermal therapy mediated by polymer-based nanoparticles to enhance checkpoint inhibitor immunotherapy for inhibiting lymph node metastasis in oral squamous cell carcinoma;Nano Today;2024-08

3. Evaluation of a Combinatorial Immunotherapy Regimen That Can Cure Mice Bearing MYCN-Driven High-Risk Neuroblastoma That Resists Current Clinical Therapy;Journal of Clinical Medicine;2024-04-26

4. A lipid/PLGA nanocomplex to reshape tumor immune microenvironment for colon cancer therapy;Regenerative Biomaterials;2024-01-01

5. Photothermal Prussian blue nanoparticles generate potent multi‐targeted tumor‐specific T cells as an adoptive cell therapy;Bioengineering & Translational Medicine;2023-12-22